Abstract | OBJECTIVES: MATERIALS AND METHODS: From 2000 to 2009, 86 patients with acute leg ischemia (Rutherford grade IB to IIA) from PAA thrombosis were treated by immediate surgery including intraoperative thrombolysis (group A: 47 cases) or preoperative thrombolysis (group B: 39 cases) followed by acute (<24 hours) or elective surgery. Chi-square tests for categorical data and time to event provided two-sided p values with a level of significance at 0.05 and all confidence intervals (CIs) at the 95% level. RESULTS: The mean follow-up was 45 months. The 2-year primary patency was 61.7% (29/47) for group A and 43.6% (17/39) for group B (hazard ratio [HR] 1.85; 95% CI: 0.96 to 3.54; p = 0.06). The 2-year secondary patency was 70.2% (33/47) for group A and 53% (21/39) for group B (HR 1.86; 95% CI: 0.91 to 3.81; p = 0.08). One-month amputation rate was 18% in group A and 29% in group B (p < 0.001), and 12-month amputation rate was 19% (9/47) in group A and 44% (17/39) in B (p = 0.05). In group A, 28% of patients required fasciotomy and in group B, 59% (p < 0.05). Effective thrombolysis allowed 82% limb salvage patency in group B. No systemic or locoregional complications during thrombolysis were recorded, but four cases of worsening ischemia were recorded. CONCLUSION: Our results suggest that the immediate surgery with intraoperative thrombolysis improved the outcome of patients with acute leg ischemia due to PAA thrombosis in terms of limb salvage.
|
Authors | Roberto Gabrielli, Maria Sofia Rosati, Alessandro Carra, Silvio Vitale, Andrea Siani |
Journal | The Thoracic and cardiovascular surgeon
(Thorac Cardiovasc Surg)
Vol. 63
Issue 2
Pg. 164-7
(Mar 2015)
ISSN: 1439-1902 [Electronic] Germany |
PMID | 24911902
(Publication Type: Comparative Study, Journal Article)
|
Copyright | Georg Thieme Verlag KG Stuttgart · New York. |
Chemical References |
- Fibrinolytic Agents
- Urokinase-Type Plasminogen Activator
|
Topics |
- Aged
- Amputation, Surgical
- Aneurysm
(diagnosis, physiopathology, therapy)
- Blood Vessel Prosthesis Implantation
(adverse effects)
- Chi-Square Distribution
- Combined Modality Therapy
- Female
- Fibrinolytic Agents
(administration & dosage, adverse effects)
- Humans
- Infusions, Intra-Arterial
- Intraoperative Care
- Ischemia
(diagnosis, physiopathology, therapy)
- Limb Salvage
- Lower Extremity
(blood supply)
- Male
- Middle Aged
- Popliteal Artery
(physiopathology)
- Preoperative Care
- Reoperation
- Retrospective Studies
- Risk Factors
- Thrombolytic Therapy
(adverse effects, methods)
- Thrombosis
(diagnosis, physiopathology, therapy)
- Time Factors
- Treatment Outcome
- Urokinase-Type Plasminogen Activator
(administration & dosage, adverse effects)
- Vascular Patency
|